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The European Pharmacopoeia 6.7 describes a liquid chromatography (LC) method for the quantification of sulindac, using a quaternary mobile phase including chloroform and with a rather long
run time. In the present study, a new method using a short sub-2µm column, which can be used on a classical HPLC system, was developed. The new LC conditions (without chloroform) were
optimized by means of a new methodology based on design of experiments in order to obtain an optimal separation.
MATERIALS AND METHODS
Analyses were performed on an Agilent technologies HPLC 1100 series.
Chromatographic conditions: reference method
Analytical column: Alltima Silica column (250 x 4.6 mm i.d., 10 µm
particle size) - Mobile phase: Acetic acid/ethanol/ethylacetate/
chlroroform (1:4:100:400 (v/v/v/v)) - Flow-rate: 2.0mL/min -
Temperature: 20°C - Detection : UV at 280 nm - Injection volume: 20µL
RESULTS 
Apparatus
Chromatographic conditions: Optimised method           
Experimental design
Analytical column: Platinum C18 Rocket column (53 x 7 mm i.d., 1.5µm
particle size) - Mobile phase: ACN/buffer pH2 (see experimental design
section) - Flow-rate: 3.0mL/min - Temperature: 35°C - Detection : UV at
340 nm - Injection volume: 100µL
Four HPLC factors were investigated using DoE methodology through a design matrix. All of the factors were
quantitative (see table 1). The objective of this study was to determine the optimal chromatographic
conditions allowing us to obtain a separation criterion of at least 0 minutes (i.e. baseline resolved peaks) with
a probability of at least 90%.
A summary of the optimal values for each factor allowing the achievement of the higher probability ensuring a separation of at least 0 minutes with baseline-resolved peaks is shown in Table 2.
Plateinit (min) ACNlower (%) ACNupper (%) Gradient time (min)
Optimal values
P(separation> 0)>0.9 1 40.5 55 3.6
The developed HPLC method for the
quantification of sulindac and its
related impurities divided the run time
of analyses by three compared to the
reference method. Figure 4a and 4b
show the optimal predicted and
experimental chromatograms. As can
be seen, the predicted retention times
were found to be very close to the
experimental values and an
acceptable separation was obtained
within an analysis time of 6 minutes.
Plateinit (min) ACN lower (%) ACNupper (%) Gradient time (min)
Levels 0-1 15-30-55 55-60-65 1-3-5
Central point 0-0.5-1 30 60 3
Maximum 
effect linear quadratic quadratic quadratic
Table 1: Description of the levels of four factors involved in the experimental design
Table 2: Summary of the optimal values for each factor of the experimental design
CONCLUSIONS
ACKNOWLEDGEMENTS :The authors acknowledge the Walloon Region of Belgium and Arlenda®
Reference method
Figure 1 : Chromatogram of the reference method.
Optimised method
As can be seen in Figure 1, the reference method enabled the separation of
all the compounds within 18 minutes and was completed within 25 minutes.
Figure 5 : Accuracy profiles of (a) sulindac, (b) E-sulindac, (c) sulphide and (d) sulphone.
Relative bias (—), ± 5% acceptance limits (- - -), 95% (sulindac) or 85% (related impurities) β-expectation tolerance limits (–
– –), and relative back-calculated concentrations (●).
Figure 3 :Surface of probability to reach
S>0.The design space is surrounded by black
lines for an expected probability to have well-
separated peaks is 0.9. Factors optimal values
are placed between parentheses.
Validation method
Figure 4 : (a) Experimental chromatogram recorded at optimal solution. (b) Predicted
chromatogram at optimal condition. (1: sulindac, 2: sulphide, 3: sulphone, 4: E-sulindac)
Figure 2 illustrates the quality of the fit of the observed retention times versus the predicted retention times
using the statistical models previously described. Most of the residuals were mainly located within the
interval [-0.2 min, 0.2 min]. Figure 3 shows the probability surfaces in different directions of the space around
the optimal solution (for each graph, two factors were fixed at their optimal values). As we can see, the best
probability surface was obtained when the duration of the initial isocratic plate was around 1 minute.
Figure 2 : Experimental retention times versus
predicted ones. Residuals are depicted at the bottom
right corner.
An analytical method for the quantification of sulindac and its related impurities was developed using a short column with sub-2 µm particles on a classical HPLC system. This method was optimised
using DoE methodology and the DS concept. Under optimised conditions, the analysis time was considerably reduced (by about 3-fold). Furthermore, we did not use chloroform unlike in the EP reference
method. Finally, this particular method was validated successfully using an accuracy profiles approach for sulindac and its related substances.
The calibration and validation standards were prepared by mixing and diluting the
stock solutions with phosphate buffer solution (pH 7.4; 50 mM) to reach the
concentration levels: 100/10; 100/5; 100/1; 100/0.5; 50/0.25; 25/0.125; 1/0.005;
0.5/0.0025 µg/ml (sulindac concentration/ concentrations of related impurities,
respectively.
An original approach using accuracy profiles based on tolerance intervals was
applied to evaluate the reliability of the results. The tolerance interval used was a
“β-expectation tolerance interval” defining an interval in which it is expected that
each future result will fall with a defined probability (β). It is therefore a predictive
methodology. This tolerance interval is computed for each validation standard
concentration level, using their estimated intermediate precision standard deviation
and bias. By joining together the upper tolerance limits on the one hand and the
lower tolerance limits on the other hand, the method defines an accuracy profile
(fig.5).
